The current study is aimed to evaluate the effect of COVID-19 vaccine on human EEG and the persistence of the effect. Within a one-year-long resting EEG study period, the healthy male subject was administered two Comirnaty doses three weeks apart to prevent COVID-19. Fourteen recordings were acquired from the subject in one year: twelve reference and two post-vaccination recordings after administrating the second dose of Comirnaty. The changes in absolute powers of EEG frequency bands, EEG spectral asymmetry index (SASI), and Higuchi's fractal dimension (HFD) were analyzed. The results indicated a statistically significant increase in absolute gamma power, SASI and HFD values on the fifth day after the vaccination, while the EEG had restored its normal character on the twelfth day after vaccination. These measures seem to have higher sensitivity for the detection of the effects of the vaccine Clinical Relevance- This is the first study evaluating COVID-19 vaccine effect on healthy human EEG. The study indicated that the vaccine disturbs EEG but the impact is not long-lasting.

Download full-text PDF

Source
http://dx.doi.org/10.1109/EMBC48229.2022.9871524DOI Listing

Publication Analysis

Top Keywords

covid-19 vaccine
12
human eeg
8
eeg study
8
day vaccination
8
eeg
7
vaccine
5
study
5
changes eeg
4
eeg measures
4
measures recipient
4

Similar Publications

The rapid development and deployment of mRNA and non-mRNA COVID-19 vaccines have played a pivotal role in mitigating the global pandemic. Despite their success in reducing severe disease outcomes, emerging concerns about cardiovascular complications have raised questions regarding their safety. This systematic review critically evaluates the evidence on the cardiovascular effects of COVID-19 vaccines, assessing both their protective and adverse impacts, while considering the challenges posed by the limited availability of randomized controlled trial (RCT) data on these rare adverse events.

View Article and Find Full Text PDF

Background: Mobile Health Clinics (MHCs) are an alternate form of healthcare delivery that may ameliorate current rural-urban health disparities in chronic diseases and have downstream impacts on the health system by reducing costs. Evaluations of providers' time allocation on MHCs are scarce, hindering knowledge transfer related to MHC implementation strategies.

Methods: Retrospective economic cost was assessed using business ledgers and expert assessments in 2023 US Dollar (USD) from 2022 to 2023.

View Article and Find Full Text PDF

Background: While vaccination remains crucial in mitigating the impact of the COVID-19 pandemic, several ocular adverse events has been reported, including Acute Zonal Occult Outer Retinopathy (AZOOR) complex.

Case Presentation: A 31-year-old female presented declined best corrected visual acuity (BCVA) and flashes in both eyes three days following second recombinant mRNA COVID-19 vaccine (Moderna). Fundus autofluorescence (FAF) illustrated speckled hyper-AF lesions surrounding right eye torpedo maculopathy site and hyper-AF lesions in the left macula.

View Article and Find Full Text PDF

Are psychological attitudes towards vaccination an expression of personality? A cross-sectional study on COVID-19 vaccination in France.

BMC Public Health

January 2025

Emerging Diseases Epidemiology Unit, Institut Pasteur, 25-28 Rue du Docteur Roux, Bâtiment Laveran, Paris, 75015, France.

Background: The capacity of the 7C model's psychological antecedents, which include confidence in vaccines, complacency, convenience, calculation, collective responsibility, confidence in the wider system, and social conformism, to explain variance in COVID-19 vaccine intentions and behaviours has been documented. However, it remains unclear whether the attitudes represented by the 7C psychological antecedents are specific to vaccination or if they are, in fact, an expression of underlying personality traits.

Methods: From February to June 2022, French adults completed self-administered questionnaires assessing COVID-19 vaccination history, the 7C antecedents, and personality traits ("ComCor" and "Cognitiv" studies).

View Article and Find Full Text PDF

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Nat Commun

January 2025

Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Neutralizing antibody titer has been a surrogate endpoint for guiding COVID-19 vaccine approval and use, although the pandemic's evolution and the introduction of variant-adapted vaccine boosters raise questions as to this surrogate's contemporary performance. For 985 recipients of an mRNA second bivalent or monovalent booster containing various Spike inserts [Prototype (Ancestral), Beta, Delta, and/or Omicron BA.1 or BA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!